Clinical Phenotypes of Patients with Anti-DFS70/LEDGF Antibodies in a Routine ANA Referral Cohort
Figure 2
Antinuclear antibodies measured by ELISA and anti-DFS70 antibodies by chemiluminescent immunoassay (CIA) in samples with DFS pattern versus samples with other patterns. (a) Anti-DFS70 antibodies were significantly more prevalent (91.0% versus 3.0%) and their titers higher in samples with DFS pattern compared to samples with other patterns (). (b) In contrast, antinuclear antibodies were significantly less prevalent (35.0% versus 67.0%) and their titers lower in samples with DFS pattern compared to samples with other patterns (). Cut-off values are indicated by the red line.
